Industrial contradictions show that the planting industry is facing a huge turning point

The contradiction between industrial development and resource consumption, the urgent need for innovation in technology and products and other factors have prompted the industry to usher in major changes As the main driving force for the strong growth of the import and export of traditional Chinese medicine, the development of plant extracts has always been concerned, which can be seen from the popularity of the fifth "development and innovation of Chinese plant extracts" forum held at the same time as the 10th World pharmaceutical raw materials China exhibition Although the export data is still gratifying, experts in the industry generally believe that "the planting industry is facing a huge turning point" The contradiction between industrial development and resource consumption, the urgent need for innovation in technology and products and other factors make the industry usher in a major change There is still room for sustained growth in the first quarter of this year The import and export volume of traditional Chinese medicine products reached US $870 million, an increase of 33.5% year-on-year; the export volume reached US $690 million, an increase of 40.3% year-on-year, which shows the rare strong in recent years Among them, the proportion of extract in the import and export volume of traditional Chinese medicine is more than 60% According to the statistics of China Customs, in the first quarter of this year, the import and export volume of plant extracts reached US $500 million, accounting for 57.2% of the total export volume of traditional Chinese medicine, a year-on-year increase of 37.4%, and the total import and export volume also increased significantly, a year-on-year increase of 45.0% Among them, the export volume of plant extracts was US $440 million, up 44.3% year on year, accounting for 63.7% of the export volume of traditional Chinese medicine; the export volume was 27000 tons, up 52.3% year on year; the average export price slightly decreased, down 5.3% year on year According to China Medical Insurance chamber of Commerce, in the first quarter of this year, the development situation of plant extracts in China was good, which opened a good start for the development of plant extracts import and export industry in 2010 At present, the global demand for plant extracts is still growing, and there is still a lot of room for growth in the domestic trade of plant extracts Call for innovation and self-discipline Although the latest data presented by the market is not vulgar, it can not cover up the hidden dangers of the whole industry: the quality problems of some products have hit consumers' confidence in the Chinese market; the plant resources are not enough to support the continuous development of the plant extraction industry according to the existing model, especially the low level of product design and production technology, and the comprehensive utilization of plant resources has not been realized Li Chunhua, President of Beijing Green Gold Biotechnology Co., Ltd., believes that the game between industry growth and resource consumption is pushing the plant industry to a new stage of development In his opinion, the planting and lifting industry is bound to develop in the direction of production safety, consumer health and environmental protection "Although green production will face many bottlenecks, this is the inevitable way." Li Chunhua said However, dramatic changes in the international market will play a catalytic role in the transformation of the industry "Several of our major enterprises can feel the substantial changes in the international market more intuitively by facing foreign end customers directly." Zhang Chengcheng, President of China plant extract association and general manager of Xi'an Haotian Bioengineering Technology Co., Ltd According to him, in the U.S market, FDA requires large-scale food supplement enterprises to pass cGMP certification by the end of June this year, which will inevitably affect the source, which means that all requirements will be more stringent for Chinese plant lifting enterprises "The US market is moving towards rationality Once the United States requires cGMP certification for its domestic small and medium-sized food supplement enterprises, the small and medium-sized enterprises connected with China are likely to face a huge test in the next two to three years " Zhang Chengwen said Apart from the U.S market, Europe and Japan are also not optimistic Although the overall market is not obviously troubled by the euro area economy, the European market is showing a significant trend of localization, and customers' demand for certification, technical data and relevant clinical data in product selection is significantly increased In the Japanese market, Chinese products are seriously questioned, and even appear obvious exclusion tendency Under the international situation of more and more localization, more and more strict security and standards, the fundamental driving force for the development of China's plant industry is nothing more than innovation and security "There is no gap between China's planting industry and the international industry Based on the development of traditional Chinese medicine, we should develop safe traditional Chinese medicine in an internationally acceptable way of expression " In Zhang Chengwen's view, it's not too hard, but impetuosity and speculation are flooding the whole industry, which urgently needs self-discipline and abandons price war and vicious competition "In the past, it was very chaotic, and now there is a trend: major enterprises have several advantageous products, have the right to speak, and can moderately raise prices, but they must adhere to a certain bottom line, so that the law of the market can be presented normally." Zhang Chengwen said.